7 reports

  • Generics Pricing & Reimbursement Scenario

Budesonide inhalation suspension is an inhaled corticosteroid medicine used to control and prevent asthma symptoms in children aged ## months to ## years.

  • Health Economic Indicators
  • Europe
  • World
  • Mylan Inc.
  • Teva Pharmaceutical Industries Ltd.

asthma drug Nucala (mepolizumab) In September 2015, the ICER published draft reviews of the effectiveness, value, and value-based price benchmarks" of the PCSK## inhibitors Praluent (alirocumab) and Repatha (evolocumab).

  • Health Economic Indicators
  • Hospital
  • United States
  • CVS Caremark Corporation
  • ESI Group

THE AVERAGE COST-OF-CASE MANAGEMENT FOR BRONCHIAL ASTHMA DURING THE PERIOD FROM 1994-2005 WAS $## PER YEAR.

  • Health Economic Indicators
  • Canada
  • North America
  • United States
  • Mexi co

Budesonide inhalation suspension is an inhaled corticosteroid medicine used to control and prevent asthma symptoms in children aged ## months to ## years.

  • Health Economic Indicators
  • United States
  • Mylan Inc.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.

Drugs for the treatment of epilepsy, psychosis, schizophrenia, asthma, and chronic degenerative autoimmune diseases.

  • Health Economic Indicators
  • Healthcare
  • Hospital
  • Pharmacy
  • Greece

The first pay-for-performance scheme agreed between the VWS and a manufacturer was implemented in August 2012, covering Novartis' severe asthma drug Xolair (omalizumab).

  • Health Care Provider
  • Health Economic Indicators
  • Netherlands
  • Achmea Group
  • Novartis AG

In Valencia a prescribing control system is in operation under which an IT programme selects the most efficient treatment option for each patient in treatment areas such as asthma/ chronic obstructive pulmonary disease (COPD), diabetes, dyslipidaemia, hypertension and osteoporosis.

  • Health Economic Indicators
  • Hospital
  • Pharmaceutical
  • Pharmacy
  • Spain